Subsidies & Funding

We empower medical innovation

Project Management

We manage research & innovation projects

Business Strategy

We support successful commercialisation



ttopstart has supported the foundation of StemCell2MAX and is now engaged in supporting its growth through strategy and funding services.

StemCell2MAX is a spin-off from Instituto de Medicina Molecular and markets a proprietary mix of neurotrophic factors that are able to stimulate the expansion of haematopoietic stem cells (HSCs), highly improving their utility in research and potential clinical use. The value proposition of StemCell2MAX's products relies on the ability to expand HSCs up to 20 times over the current state-of-the-art, while maintaining their unique stem cell properties, as published in Nature (Fonseca-Pereira et al, Nature 2014). StemCell2MAX markets a proprietary mix of neurotrophic factors that specifically control cord blood HSC survival, therefore expanding HSCs while maintaining their stemness.

"Great support and ability to identify the critical issues and requirements for a competitive application. The team is always available and provides extremely relevant inputs.” 



ir. Jasper Levink